Disclosure: This article may contain affiliate links. If you click a link and make a purchase, we may receive a commission at no additional cost to you. All opinions remain our own.
About this guide: This pricing analysis reflects Novi's published terms and product pages as of May 2026. Pricing is subject to change. Compounded medications referenced are not FDA-approved finished drugs. Nothing in this article is medical or financial advice. Verify all current pricing on the official platform before any purchase.
The number you see on Novi's homepage — $174 — is real. It just isn't the full picture.
Most reviews of compounded GLP-1 telehealth platforms quote the headline price and stop. The published terms of service tell a more specific story about what you're committing to, what's included, and what changes if you cancel. This breakdown reads the terms alongside the marketing — so the cost decision is made on the actual numbers, not the front-page ones.
The Headline Pricing
Novi publishes two starting prices on the homepage. Compounded semaglutide is listed “from $174” and described as having the same active ingredient as Ozempic and Wegovy. Compounded tirzepatide is listed “from $283” and described as having the same active ingredient as Mounjaro and Zepbound. Both are labeled as monthly subscription pricing.
The “from” qualifier matters. These are starting prices for the lowest dose tiers — the prescriber's titration plan determines actual monthly cost. GLP-1 medications are typically initiated at low doses to minimize gastrointestinal side effects, then titrated upward over weeks to months. As dose increases, pricing on most compounded-GLP-1 telehealth platforms also increases. Novi's published materials don't specify the full per-tier price ladder. Confirm during the consultation.
The compounded versus brand-name distinction is the foundational pricing premise. Brand-name semaglutide (Wegovy) and brand-name tirzepatide (Zepbound) carry list prices well above $1,000 per month for cash-pay patients without insurance. The compounded category exists because of that gap — and because the FDA shortage of these molecules from 2022–2024 created a legal pathway for outsourcing facilities to compound copies. Both shortages have since been resolved, and the regulatory pathway is now actively being narrowed (more on that below). The $174 and $283 prices reflect that compounded category structure.
What's Included in the Monthly Fee
Per Novi's published program description, the monthly subscription fee covers: a 4-week supply of medication shipped each month, the supplies needed to administer it, a $20 independent physician consultation fee paid to an independent medical group, unlimited provider check-ins for dose adjustments and questions, and coaching at no additional cost.
The platform describes pricing as “all-in and transparent — no hidden fees, no separate membership, medication included.” Free 2-day shipping is referenced in the marketing. The published terms separately note that the user is responsible for “any applicable sales, use, duty, customs or other governmental taxes, levies or fees” and any shipping and handling charges shown at the time of purchase.
The reasonable read: the marketing's “all-in” framing applies to the routine monthly subscription cost, and any taxes or jurisdictional fees layer on top. Verify the order summary before confirming the first payment.
The 3-Month Commitment — In the Terms, Not the Marketing
This is the part that doesn't appear on the homepage and does appear in the terms of service. Quoting directly from Novi's published Terms of Service: “Subscription based Products and/or Services require a minimum 3-month commitment as We incur significant upfront cost to provide these Products and/or Services to you. By enrolling in Subscription Services, you agree to pay for a minimum of three (3) consecutive months of Service.”
The terms further specify: “the first month's fee as well as the monthly fee for the following two months (for a total of three (3) consecutive months) is charged at the time of purchase and is non-refundable unless our Providers deem it is not medically appropriate to prescribe you the ordered Products and/or Services.”
What this means in practical terms. When a new patient signs up and is approved for a prescription, all three months are charged upfront — or charged on the standard monthly cadence with the user contractually obligated to all three. The only refund pathway in the published terms is if a provider decides the treatment isn't medically appropriate before any prescription is dispensed. After that point, refunds aren't available under the terms.
For a $174/month semaglutide subscriber, the 3-month commitment translates to roughly $522 in obligated spend. For a $283/month tirzepatide subscriber, roughly $849. Those are the actual numbers a prospective Novi patient is committing to, regardless of how they respond to the medication.
The Cancellation Mechanics
Novi allows cancellation at any time, but the timing rules determine whether cancellation actually stops further charges. Per the published terms, cancellation must be submitted at least 15 days before the next monthly processing date — and only after the 3-month commitment has concluded — to stop subsequent renewals.
Cancellation can be submitted via email to support@joinnovi.com (the published support address) or through the patient dashboard on the website.
The other dimension worth knowing: once a prescription is dispensed or shipped, it cannot be returned or refunded under the published terms. That language applies whether or not the medication has actually been delivered to the patient — “dispensed” in pharmacy operations typically refers to the moment the pharmacy fills the prescription, before physical shipment.
The terms also explicitly address chargebacks: “False credit card disputes will be aggressively defended and customers who attempt to dispute charges to circumvent the 3-month commitment will be sent to collections and/or have further legal action pursued.” That's a clear operational stance. The 3-month commitment is contractually enforced.
The April 30, 2026 FDA Proposal — Pricing Implications
Two days before this analysis was written, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list. The public comment window runs through June 29, 2026. If finalized, the rule narrows the legal pathway for large-scale outsourcing facilities to produce compounded versions of these molecules from bulk active pharmaceutical ingredient.
The pricing implication is direct. The $174 and $283 price points exist because compounded sourcing is materially cheaper than brand-name finished pharmaceutical products. If 503B compounding of these molecules is foreclosed, platforms reliant on that pathway face a sourcing challenge — some may shift to 503A patient-specific compounding (a different legal framework, generally smaller volumes), some may pivot toward brand-name medications at brand-name prices, and some may exit the category. We discuss the regulatory mechanics in more depth in our Novi compounded vs brand analysis.
What this means for a prospective Novi patient evaluating the 3-month commitment today: pricing stability over the commitment window is not certain at the category level. The published terms allow Novi to adjust subscription pricing with notice. Whether and how the platform adapts its pricing to a finalized regulatory shift is something that will only be visible over the coming weeks. For broader context on the platform's clinical structure and what to ask before signing up, see the full Novi review.
What the Total 3-Month Cost Looks Like
The starting-price scenario, on the lowest published dose tier of compounded semaglutide, is roughly $522 over 3 months ($174 × 3) before any taxes. For compounded tirzepatide at the starting tier, roughly $849 ($283 × 3). Those numbers assume no dose escalation triggers a higher price tier inside the 3-month window — Novi's published materials don't disclose whether titration changes monthly cost, so confirm directly during the consultation.
Compared to brand-name pricing for cash-pay patients, that 3-month figure is substantially lower than three months of Wegovy (often $1,300+/month at retail) or Zepbound (similarly priced). It is meaningfully higher than a one-month trial of any of those platforms — because Novi's structure does not allow a one-month trial.
For consumers comparing Novi against other compounded-GLP-1 telehealth platforms, the headline price differentials are modest, but commitment structures, refund policies, and pharmacy network transparency vary. Our Novi vs SynergyRx vs TeleHealth Med comparison covers those dimensions head-to-head.
What's Not in the Pricing — But Affects Your Total Cost
Three categories of cost don't appear in Novi's headline pricing and may apply to specific situations.
Initial laboratory testing, if a provider recommends bloodwork as part of the eligibility screening. Novi's published process is primarily online intake, with lab work requested at provider discretion. Testing costs would typically be paid separately to a third-party lab.
Brand-name medication costs, if the provider determines a compounded option isn't appropriate and a branded medication is prescribed instead. Novi's primary offering is compounded; it isn't structured as a brand-name distributor at brand-name price points.
Side-effect-related costs. Most are minor and self-managed (anti-nausea over-the-counter products, hydration, dietary adjustments during titration). In rare cases involving serious adverse events, in-person clinical care may be necessary, and that care is outside Novi's telehealth scope. The platform's terms emphasize that telehealth is not a substitute for emergency medical care.
For a detailed look at side-effect management and the specific terms around how Novi handles cancellation when a patient is experiencing tolerability issues, see our Novi side effects and cancellation policy review.
The Honest-Broker Read on Novi's Pricing
Novi's pricing is competitive within the compounded-GLP-1 telehealth category. The headline numbers are real. The 3-month commitment is the structural cost detail that most reviews don't surface and that prospective patients should account for in their decision. Compared to the alternatives that operate without commitments, the trade-off is lower per-month pricing in exchange for less flexibility.
For broader context on how this category functions and what every prospective patient should evaluate before signing up — pricing, clinical structure, and the regulatory environment — see the TotalCareMedical.com weight management coverage at our weight management hub.
The pricing is fair for what's offered. The commitment structure is a real consideration. The regulatory environment is the wild card. Make the decision on all three, not just the front-page number.